Moneycontrol PRO

Cadila: a formidable play in Covid times and beyond

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

September 25, 2020 / 05:47 PM IST
Cadila: a formidable play in Covid times and beyond

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Cadila’s Covid vaccine undergoing phase II trials; seeking a range of options - Strong foray into injectables, biologics – a key watch - R&D expense of 7-8 percent of sales heavily allocated for biosimilars - Growing India presence provides stable cash flow visibility Cadila Healthcare (CMP: Rs 376, Market cap: Rs 38,497 crore), known to be one of India’s formidable plays on Covid solutions is a worth a watch, even after the fading of the hydroxychloroquine (HCQS) opportunity. HCQS, which was touted as an early solution...

  • PRO Panorama

    Moneycontrol Pro Panorama | Bear Bottom

    May 25, 2022 / 04:36 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Modi govt turns 8, Zomato’s stock appeal, the dark side of Russia sanctions, windfall from stock rout and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | People’s Bank of China rides to the rescue 

    May 21, 2022 / 10:10 AM IST

    The central bank of China – an outlier in these times of quantitative tightening – has eased its policy to salvage the Chinese economy. And the messaging is not lost on global growth

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers